Kramer, P. 2022. Dual Blockade of Inhibitory Immunoreceptors TIGIT and PD-1 Produces Optimal Synergistic Anti-Tumor Effects. Midwestern Journal of Undergraduate Sciences. 1, 1 (Oct. 2022), 3–4. DOI:https://doi.org/10.17161/mjusc.v1i1.18573.